Breast cancer panel halves turnaround time: Wei Shen, Ph.D.
Jul 25, 2023•11 min•Ep. 242
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Wei Shen, Ph.D., explains how Mayo Clinic Laboratories' new breast cancer panel provides rapid results to guide critical treatment decisions.
(00:32)
Could you provide our listeners with a little bit about yourself and your background?
(01:28)
Could you give us a brief overview of the new rapid hereditary breast cancer panel?
(03:42)
Can you describe a little bit of the rationale behind the design and how it differs from similar tests?
(05:03)
Can you tell us a little bit more about which patients should have this testing?
(06:00)
How are the results of the hereditary breast cancer panel used in patient care?
(08:14)
Is there anything else you would like to add about the panel?
For the best experience, listen in Metacast app for iOS or Android